From: Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival
 |  | Disease-free survival |  |  |  |  | Overall survival |  |
---|---|---|---|---|---|---|---|---|
Haplotype | Relapse, N (%) | No relapse, N (%) | aHR (95 % CI) a | P | Death, N (%) | Alive, N (%) | aHR (95 % CI) b | P |
G-A-T-C-A | 22 (25.9) | 152 (39.9) | 1 (reference) | Â | 9 (20.9) | 167 (38.8) | 1 (reference) | Â |
C-A-T-C-G | 24 (28.2) | 100 (26.3) | 1.29 (0.71-2.34) | 0.411 | 13 (30.2) | 113 (26.2) | 1.73 (0.72-4.13) | 0.217 |
G-A-T-C-G | 27 (31.8) | 63(16.5) | 2.66 (1.49-4.73) | 0.001 | 15 (34.9) | 78 (18.1) | 3.11 (1.34-7.23) | 0.008 |
G-A-C-C-A | 5 (5.9) | 12 (3.2) | 1.76 (0.66-4.71) | 0.262 | 2 (4.65) | 16 (3.7) | 2.22 (0.47-10.6) | 0.316 |
Others | 7 (8.24) | 54 (14.2) | 0.66 (0.28-1.56) | 0.343 | 4 (9.3) | 57 (13.2) | 1.02 (0.31-3.33) | 0.978 |
Total | 85 (100) | 381 (100) | Â | Â | 43 (100) | 431 (100) | Â | Â |